Skip to content

Visual Rehabilitation of Patients With Myopic Maculopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01244074
Enrollment
Unknown
Registered
2010-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2010-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopic Maculopathy

Brief summary

The Visual Pathfinder (LACE inc.) offers a non- invasive, patient- centered visual rehabilitation system based on an acoustic biofeedback. The investigators wanted to evaluate its usefulness in the improvement of visual function in visually impaired patients with high myopia.

Interventions

BEHAVIORALbiofeedback training

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
35 Years to 57 Years

Inclusion criteria

* high myopia (range 9-15 D) visited at the Outpatient Medical Retina's Hospital A. Fiorini Terracina (LT), University of Rome La Sapienza, Polo Pontino. The diagnosis of myopic maculopathy was made on the basis of a comprehensive ophthalmological evaluation which included: biomicroscopic examination of anterior and posterior segment, fluorescein angiography (FAG) (Heidelberg HRA-2, FA module Heidelberg, Germany), optical coherence tomography (OCT), Spectral Domain (Heidelberg HRA-2, OCT module Heidelberg, Germany) and microperimetry with microperimeter MP-1 (Nidek Technologies, Padova, Italy).

Exclusion criteria

* The investigators have excluded patients with other eye diseases (glaucoma, AMD, retinal detachment, etc.), uncooperative patients and persons with opacity of the dioptric media.

Design outcomes

Primary

MeasureTime frame
improvement of visual performance

Secondary

MeasureTime frame
improvement of visual acuity, retinal sensitivity, fixation stability

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026